Clinical Takeaway: AMH is a powerful roadmap tool, not a fertility verdict. Pair your results with clinical ultrasound and expert guidance to personalize your family planning or fertility preservation strategy.

1. What is Anti-Müllerian Hormone (AMH)?

Anti-Müllerian Hormone (AMH) is a dimeric glycoprotein secreted exclusively by the granulosa cells of primary, pre-antral, and small antral follicles (measuring 2 to 8 mm) in the ovaries. Because these growing follicles reflect the microscopic resting pool of primordial eggs, AMH serves as the premier clinical blood biomarker for assessing ovarian reserve.

Unlike follicle-stimulating hormone (FSH) and estradiol, which fluctuate markedly across the phases of the menstrual cycle, AMH levels remain relatively stable throughout the month. This allows AMH to be measured via a simple blood draw on any cycle day.

      [Primordial Follicle]  --->  [Pre-antral & Small Antral Follicles (2-8 mm)]
          (No AMH)                         │
                                           ▼
                                [Granulosa Cells Secretion]
                                           │
                                           ▼
                                 [AMH Circulating in Blood]

2. Interpreting AMH Reference Ranges

AMH values must be interpreted in conjunction with a patient’s age and an Antral Follicle Count (AFC) performed via transvaginal sonogram:

AMH Level (ng/mL)	Reserve Classification	Clinical & Fertility Implications
< 0.5 ng/mL	Very Low / Diminished (DOR)	Limited remaining egg pool. Requires expedited fertility evaluation if planning conception.
0.5 – 1.1 ng/mL	Low Reserve Range	Slightly reduced follicular pool; may yield fewer eggs during IVF stimulation cycles.
1.2 – 3.5 ng/mL	Normal / Optimal Reserve	Balanced egg quantity for reproductive age; standard responsive window for fertility treatments.
> 4.0 – 5.0+ ng/mL	High / Polycystic Pool	Abundant follicle pool; typical in PCOD/PCOS. Risk of Ovarian Hyperstimulation (OHSS) during IVF.

3. What AMH Can and Cannot Tell You

One of the most widespread misconceptions in fertility medicine is treating AMH as an absolute predictor of natural fertility. Understanding its physiological boundaries is essential:

What AMH Accurately Tells You	What AMH Does NOT Measure
✔ Quantity of remaining pre-antral and antral follicles	✖ Egg Quality or Chromosomal Competence
✔ Estimated response to ovarian stimulation for IVF	✖ Probability of natural conception in unassisted cycles
✔ General timeline for proactive fertility preservation (egg freezing)	✖ Patency of fallopian tubes or uterine receptivity
✔ Presence of polycystic ovarian morphology	✖ Sperm health, motility, or partner factors

Key Principle: Egg Quality vs. Quantity A 28-year-old with a low AMH of 0.8 ng/mL often has a higher chance of natural conception than a 42-year-old with an AMH of 2.5 ng/mL because cellular age dictates chromosomal health (euploidy), whereas AMH solely reflects egg count.

4. Clinical Applications & Action Plan

Whether you are actively attempting conception, considering egg preservation, or assessing reproductive longevity, structured evaluation includes:

Comprehensive Workup

• Serum AMH + Day 3 FSH & Estradiol
  
• Transvaginal Antral Follicle Count (AFC)
  
• Thyroid Panel (TSH, Free T4, Anti-TPO)
• Vitamin D levels (Deficiency can falsely lower AMH)

Supportive Protocols

• Coenzyme Q10 (Ubiquinol) for mitochondrial energy
• Antioxidant support (Vitamin E, C, Alpha-Lipoic Acid)
• Minimizing endocrine disruptors (BPA, phthalates)
• Targeted fertility consultation for DOR or OHSS risk

5. Frequently Asked Questions (FAQ)

Q: Can I raise my AMH level naturally?

A: Because women are born with all the eggs they will ever have, the true biological ovarian reserve cannot be increased. However, correcting severe Vitamin D deficiency, stopping smoking, and balancing thyroid disorders can optimize active follicle recruitment and mildly normalize test values.

Q: Does being on birth control pills affect AMH?

A: Yes. Prolonged use of combined oral contraceptives temporarily suppresses follicle growth, which can temporarily reduce serum AMH by up to 20–30%. Testing is best repeated 1–2 months after stopping hormonal birth control.